August 3, 2017

 

Important Information from the Georgia AAP

New Law Changes Georgia Prescription Drug
Monitoring Program; Pediatricians Must Register, But ADHD Medications Are Excluded

Recently all physicians in Georgia received notification from the Georgia Dept. of Public Health (DPH) about changes to the Georgia Prescription Drug Monitoring Program (PDMP) mandated by House Bill 249 which passed the General Assembly in March. The bill was passed in part to curb the opioid abuse problem now common in Georgia and other states across the country.

The new law requires prescribers (e.g. physicians) with DEA numbers to register with the PDMP if they have not already done so. Currently only about 10% of all physicians are registered. This must be completed by January 1, 2018. So members are reminded to do this by the end of the year. In its June 28th memo, DPH outlined a system based on your birth month to register, given the heavy volume of new registrations they anticipate. Please click below to the DPH memo, and note the section on page 2 which outlines how to register and what you will need when you register at the website indicated.  (Obviously, July is now over, but those of you with birthdays in the January-March period should go ahead and register anytime between now and year-end.)

Click here for the DPH memo from Commissioner Brenda Fitzgerald, MD.

Secondly, the new law requires that the prescriber check the PDMP before prescribing certain Schedule II drugs & benzodiazepines, and at certain intervals thereafter. However, stimulants used in the treatment of ADHD are NOT included in the list of Schedule II drugs which would require a physician to check before prescribing. The Georgia AAP followed this bill closely throughout the session and advocated to ensure these drugs were exempted from the bill. Since they are so routinely prescribed for ADHD treatment, such a requirement would have posed an unreasonable administrative burden on practices seeing these children. The authors of the legislation recognized this and we are appreciative of that. (If you would like to see the list of Schedule II drugs that are included in the law, visit the Georgia AAP website and look under the Legislative page.)

Should you have any questions, contact Fozia Khan Eskew (feskew@gaaap.org) at the Georgia AAP office (404-881-5074). Thank you.

Melina Willingham, MD
Chair, Legislative Committee

This message was also posted to the Georgia AAP Practice Managers Listserv.